Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deulevodopa + carbidopa versus levodopa + carbidopa pharmacokinetic crossover study in healthy volunteers
NL-OMON42683Phase 1Active, not recruiting
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of deulevodopa, levodopa and carbidopa in Parkinson's disease (PD) (2 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Pharmacokinetics, Safety and 1 more. Started Dec 2015; status: active, not recruiting.
02
Drugs
deulevodopalevodopacarbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON42683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42683.